Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of AMREP CORP. from Q1 2017 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
AMREP CORP. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q1 2017 to Q2 2025.
  • AMREP CORP. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 31 Jul 2025 was $49.4M, a 20.9% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

AMREP CORP. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $49.4M +$8.53M +20.9% 31 Jul 2025 10-Q 09 Sep 2025
Q1 2025 $39.9M +$9.68M +32% 30 Apr 2025 10-Q 09 Sep 2025
Q4 2024 $37.4M +$19.4M +108% 31 Jan 2025 10-Q 07 Mar 2025
Q3 2024 $40.6M +$23.9M +143% 31 Oct 2024 10-Q 13 Dec 2024
Q2 2024 $40.9M +$19.1M +87.8% 31 Jul 2024 10-Q 09 Sep 2025
Q1 2024 $30.2M +$10.2M +51.3% 30 Apr 2024 10-Q 09 Sep 2025
Q4 2023 $18M +$5.61M +45.2% 31 Jan 2024 10-Q 07 Mar 2025
Q3 2023 $16.7M +$3.83M +29.7% 31 Oct 2023 10-Q 13 Dec 2024
Q2 2023 $21.8M +$5.86M +36.8% 31 Jul 2023 10-Q 13 Sep 2024
Q1 2023 $20M +$4.27M +27.2% 30 Apr 2023 10-K 25 Jul 2025
Q4 2022 $12.4M -$14.9M -54.6% 31 Jan 2023 10-Q 08 Mar 2024
Q3 2022 $12.9M -$17.4M -57.5% 31 Oct 2022 10-Q 11 Dec 2023
Q2 2022 $15.9M -$7.36M -31.6% 31 Jul 2022 10-Q 13 Sep 2023
Q1 2022 $15.7M -$9.08M -36.6% 30 Apr 2022 10-K 23 Jul 2024
Q4 2021 $27.3M +$11.9M +77.2% 31 Jan 2022 10-Q 13 Mar 2023
Q3 2021 $30.3M +$14.6M +93.3% 31 Oct 2021 10-Q 12 Dec 2022
Q2 2021 $23.3M +$6.21M +36.4% 31 Jul 2021 10-Q 07 Sep 2022
Q1 2021 $24.8M +$7.3M +41.7% 30 Apr 2021 10-K 25 Jul 2023
Q4 2020 $15.4M +$935K +6.46% 31 Jan 2021 10-Q 10 Mar 2022
Q3 2020 $15.7M +$2.8M +21.8% 31 Oct 2020 10-Q 08 Dec 2021
Q2 2020 $17.1M +$1.17M +7.37% 31 Jul 2020 10-Q 14 Sep 2021
Q1 2020 $17.5M +$3.27M +22.9% 30 Apr 2020 10-K 21 Jul 2022
Q4 2019 $14.5M +$238K +1.67% 31 Jan 2020 10-Q 11 Mar 2021
Q3 2019 $12.9M -$1.11M -7.9% 31 Oct 2019 10-Q 08 Dec 2020
Q2 2019 $15.9M +$796K +5.27% 31 Jul 2019 10-Q 09 Sep 2020
Q1 2019 $14.2M +$195K +1.39% 30 Apr 2019 10-K 27 Jul 2021
Q4 2018 $14.2M 31 Jan 2019 10-Q 09 Mar 2020
Q3 2018 $14M 31 Oct 2018 10-Q 10 Dec 2019
Q2 2018 $15.1M 31 Jul 2018 10-Q 11 Sep 2019
Q1 2018 $14M $0 0% 30 Apr 2018 10-K 27 Jul 2020
Q1 2017 $14M 30 Apr 2017 10-Q 11 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.